Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3) (NMN)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04228640 |
Recruitment Status :
Completed
First Posted : January 14, 2020
Last Update Posted : April 1, 2021
|
Sponsor:
EffePharm LTD
Collaborator:
ProRelix Services LLP
Information provided by (Responsible Party):
EffePharm LTD
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | February 27, 2021 |
Actual Study Completion Date : | March 30, 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):